SWS
GMAB icon

SYSTM Wealth Solutions’s Genmab GMAB Stock Holding History

SYSTM Wealth Solutions’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,447
Closed -$36.4K – 310
2024
Q2 		$36.4K Buy
1,447
+71
+5% +$2.01K 0.01% 299
2024
Q1 		$41.2K Buy
1,376
+196
+17% +$5.76K 0.01% 610
2023
Q4 		$37.6K Buy
+1,180
New +$37K 0.01% 629

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

SYSTM Wealth Solutions's GMAB Position: Q3 2024 in Review

SYSTM Wealth Solutions sold out of Genmab (GMAB) in Q3 2024, closing a stake of 1,447 shares — an estimated $36.4K sold.

SYSTM Wealth Solutions first reported a position in GMAB in Q4 2023 and held it in 3 quarters. The position peaked at $41.2K in Q1 2024. 223 funds tracked by Wall St. Rank hold GMAB as of Q3 2024.

  • SYSTM Wealth Solutions reported no remaining Genmab position as of Q3 2024 after selling out during the quarter.
  • SYSTM Wealth Solutions sold 1,447 Genmab shares in Q3 2024, an estimated $36.4K.
  • SYSTM Wealth Solutions first reported a position in Genmab in Q4 2023 and held it in 3 quarters.
  • SYSTM Wealth Solutions's Genmab position peaked at $41.2K in Q1 2024.
  • 223 funds tracked by Wall St. Rank held Genmab as of Q3 2024.

Based on SYSTM Wealth Solutions's 13F filing for Q3 2024, filed 14 Nov 2024.